Skip to main content
. 2006 Sep 7;12(33):5293–5300. doi: 10.3748/wjg.v12.i33.5293

Table 4.

Reasons for treatment discontinuation

PegIFN +RBV+ AMA (n = 106) IFN+RBV+AMA (n = 82)
Treatment discontinuation for any 10 (9.4%) 17 (20.7%)
Reason1
Study drug noncompliance 2 11
Demyelinizing neuropathy 1
Depression 1 1
Erythema 1
Pulmonary fibrosis 1
Hyperthyroidism 1
Hyperthyroidism & Insomnia 1
Increased ALT 1
Leukopenia 1 3
Dyspnoea, Cough, Pruritus 1
Unknown reason 1
1

Fisher’s exact test: P = 0.036.